IL127542A0 - Administration regimen of H+ K+ -ATPase inhibitors - Google Patents

Administration regimen of H+ K+ -ATPase inhibitors

Info

Publication number
IL127542A0
IL127542A0 IL12754297A IL12754297A IL127542A0 IL 127542 A0 IL127542 A0 IL 127542A0 IL 12754297 A IL12754297 A IL 12754297A IL 12754297 A IL12754297 A IL 12754297A IL 127542 A0 IL127542 A0 IL 127542A0
Authority
IL
Israel
Prior art keywords
administration regimen
atpase inhibitors
atpase
extended
profile
Prior art date
Application number
IL12754297A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL127542A0 publication Critical patent/IL127542A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12754297A 1996-06-20 1997-06-18 Administration regimen of H+ K+ -ATPase inhibitors IL127542A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals
PCT/SE1997/001098 WO1997048380A1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS

Publications (1)

Publication Number Publication Date
IL127542A0 true IL127542A0 (en) 1999-10-28

Family

ID=20403092

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12754297A IL127542A0 (en) 1996-06-20 1997-06-18 Administration regimen of H+ K+ -ATPase inhibitors
IL127542A IL127542A (en) 1996-06-20 1998-12-13 H+, K+-ATPase INHIBITORS FOR USE IN IMPROVED INHIBITION OF GASTRIC ACID SECRETION

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL127542A IL127542A (en) 1996-06-20 1998-12-13 H+, K+-ATPase INHIBITORS FOR USE IN IMPROVED INHIBITION OF GASTRIC ACID SECRETION

Country Status (28)

Country Link
US (4) US20010008900A1 (pt)
EP (1) EP0921787B1 (pt)
JP (1) JP2000512993A (pt)
CN (1) CN1178648C (pt)
AT (1) ATE252885T1 (pt)
AU (1) AU726859B2 (pt)
BR (1) BR9709838A (pt)
CA (1) CA2257405A1 (pt)
CZ (1) CZ298213B6 (pt)
DE (1) DE69725860T2 (pt)
DK (1) DK0921787T3 (pt)
EE (1) EE04606B1 (pt)
ES (1) ES2208921T3 (pt)
HK (1) HK1018590A1 (pt)
HU (1) HUP9901794A3 (pt)
IL (2) IL127542A0 (pt)
IS (1) IS2216B (pt)
NO (1) NO323295B1 (pt)
NZ (1) NZ332990A (pt)
PL (1) PL189716B1 (pt)
PT (1) PT921787E (pt)
RS (1) RS49590B (pt)
RU (1) RU2203662C2 (pt)
SE (1) SE9602442D0 (pt)
SK (1) SK284204B6 (pt)
TR (1) TR199802647T2 (pt)
UA (1) UA64715C2 (pt)
WO (1) WO1997048380A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
WO1999055157A1 (en) * 1998-04-30 1999-11-04 Sepracor Inc. R-rabeprazole compositions and methods
CA2330324A1 (en) * 1998-04-30 1999-11-04 Sepracor Inc. S-rabeprazole compositions and methods
JP4346243B2 (ja) 1998-08-10 2009-10-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア プロトン・ポンプ・インヒビターのプロドラッグ
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
DK1105105T3 (da) 1998-08-12 2006-07-17 Altana Pharma Ag Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
JPH08509736A (ja) * 1993-04-27 1996-10-15 セプラコー，インコーポレイテッド 光学的に純粋な（−）パントプラゾールを用いる胃の疾患治療の方法と組成
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DE29522419U1 (de) * 1994-07-08 2003-07-03 AstraZeneca AB, Södertälje Tablettierte Mehrfacheinheits-Dosisform
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Also Published As

Publication number Publication date
SK165598A3 (en) 1999-08-06
ES2208921T3 (es) 2004-06-16
US20070276007A1 (en) 2007-11-29
HUP9901794A2 (hu) 2000-04-28
CN1178648C (zh) 2004-12-08
EE9800435A (et) 1999-06-15
EP0921787B1 (en) 2003-10-29
DK0921787T3 (da) 2004-02-23
SK284204B6 (sk) 2004-10-05
IL127542A (en) 2006-08-01
RU2203662C2 (ru) 2003-05-10
PT921787E (pt) 2004-03-31
PL189716B1 (pl) 2005-09-30
WO1997048380A1 (en) 1997-12-24
EP0921787A1 (en) 1999-06-16
IS4923A (is) 1998-12-15
TR199802647T2 (xx) 1999-03-22
PL330910A1 (en) 1999-06-07
NO323295B1 (no) 2007-03-05
EE04606B1 (et) 2006-04-17
SE9602442D0 (sv) 1996-06-20
DE69725860D1 (de) 2003-12-04
RS49590B (sr) 2007-06-04
US20050113418A1 (en) 2005-05-26
CA2257405A1 (en) 1997-12-24
CN1222074A (zh) 1999-07-07
AU726859B2 (en) 2000-11-23
NZ332990A (en) 2000-07-28
CZ420398A3 (cs) 2000-02-16
US20010008900A1 (en) 2001-07-19
YU56698A (sh) 2004-12-31
HUP9901794A3 (en) 2002-11-28
IS2216B (is) 2007-03-15
CZ298213B6 (cs) 2007-07-25
NO985964D0 (no) 1998-12-18
NO985964L (no) 1999-02-22
UA64715C2 (en) 2004-03-15
HK1018590A1 (en) 1999-12-30
AU3469097A (en) 1998-01-07
JP2000512993A (ja) 2000-10-03
DE69725860T2 (de) 2004-09-09
ATE252885T1 (de) 2003-11-15
US20090036494A1 (en) 2009-02-05
BR9709838A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
HK1018590A1 (en) Administration regimen of h+, k+-atpase inhibitors
BG104619A (en) Oral pharmaceutical pulsed release dosage form
AP9701041A0 (en) Pyridylpyrrole compounds.
BG102259A (en) Compostions with controlled paroxetine release
AU7239996A (en) Inhibition of tumor necrosis factor alpha
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
LV11728A (lv) Farmaceitiska kompozicija
GEP20063719B (en) Prevention of Migraine Recurrence
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
AU1767297A (en) Benzo(C)quinolizine derivatives, their preparation and use as 5alpha-reductases inhibitors
BG101884A (en) Salts of the clavulanic acid
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
NO992225L (no) FremgangsmÕte for fremstilling av salter og estere av klavulansyre
AU6970394A (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
GB9323404D0 (en) Pharmaceuticals
PL318539A1 (en) Inhibition of biosynthesis
MX9804798A (es) Nuevos compuestos con efecto analgesico.
MX9804797A (es) Nuevos compuestos con efecto analgesico.
MX9709438A (es) Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos.

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: IN JOURNAL 4/2006 P. 1507 PATENT APPLICATION NO. 127542 CORRECT DATE OF APPLICATION TO- 18.06.1997

FF Patent granted
KB Patent renewed
KB Patent renewed